Abstract
Background
Hypoxic-ischemic (H-I) injury to the neonatal brain has been shown to result in rapid cell death with features of acute excitotoxicity/necrosis as well as prominent delayed cell death with features of apoptosis such as marked caspase-3 activation. BAX, a pro-apoptotic molecule, has been shown to be required for apoptotic neuronal cell death during normal development but the contribution of endogenous BAX in cell death pathways following H-I injury to the developing or adult brain has not been studied.
Materials and Methods
Bax +/+, +/−, and −/− mice at post-natal day 7 were subjected to unilateral carotid ligation followed by exposure to 45 minutes of 8% oxygen. At different timepoints following H-I, brain tissue was studied by conventional histology, immunohistochemistry, immunofluorescence, Western blotting, and enzymatic assay to determine the extent and type of cell injury as well as the amount of caspase activation.
Results
We found that bax −/− mice had significantly less (38%) hippocampal tissue loss than mice expressing bax. Some of the remaining cell death in bax −/− mice, however, still had features of apoptosis including evidence of nuclear shrinkage and caspase-3 activation. Though bax −/− mice had significantly decreased caspase-3 activation as compared to bax expressing mice following H-I, the density of cells with activated caspase-8 in the CA3 region of the hippocampus did not differ between bax +/− and bax −/− mice.
Conclusions
These findings demonstrate that endogenous BAX plays a role in regulating cell death in the central nervous system (CNS) following neonatal H-I, a model of cerebral palsy. In addition, while BAX appears to modulate the caspase-3 activation following neonatal H-I, caspase-8 which is linked to death receptor activation, may contribute to apoptotic-like neuronal death in a BAX-independent manner.
Similar content being viewed by others
References
Oppenheim RW. (1991) Cell death during the development of the nervous system. Annu. Rev. Neurosci. 14: 453–501.
Nijhawan D, Honarpour N, Wang XD. (2000) Apoptosis in neural development and disease. Ann. Rev. Neurosci. 23: 73–87.
Ferrer I, Tortosa A, Macaya A, et al. (1994) Evidence of nuclear DNA fragmentation following hypoxia-ischemia in the infant rat brain, and transient forebrain ischemia in the adult gerbil. Brain Path. 4: 115–122.
Mehmet H, Yue X, Squier MV, et al. (1994) Increased apoptosis in the cingulate sulcus of newborn piglets following transient hypoxia-ischaemia is related to the degree of high energy phosphate depletion during the insult. Neurosci. Lett. 181: 121–125.
Hill IE, MacManus JP, Rasquinha I, Tuor UI. (1995) DNA fragmentation indicative of apoptosis following unilateral cerebral hypoxia-ischemia in the neonatal rat. Brain Res. 676: 398–403.
Sidhu S, Tuor UI, Del Bigio MR. (1997) Nuclear condensation and fragmentation following cerebral hypoxia-ischemia occurs more frequently in immature than older rats. Neurosci. Lett. 223: 129–132.
Silverstein FS, Barks JD, Hagan P, Liu XH, Ivacko J, Szaflarski J. (1997a) Cytokines and perinatal brain injury. Neurochem. Int. 30: 375–383.
Pulera MR, Adams LM, Liu HT, et al. (1998) Apoptosis in a neonatal rat model of cerebral hypoxia-ischemia. Stroke 29: 2622–2629.
Cheng Y, Deshmukh M, D’Costa A, et al. (1998) Caspase inhibitor affords neuroprotection with delayed adminstration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest. 101: 1992–1999.
Taylor DL, Edwards AD, Mehmet H. (1999) Oxidative metabolism, apoptosis and perinatal brain injury. Brain Path. 9: 93–117.
Holtzman DM, Deshmukh M. (1997) Caspases: A treatment target for neurodegenerative diseases? Nature Med. 3: 954–955.
Chan SL, Mattson MP. (1999) Caspase and calpain substrates: roles in synaptic plasticity and cell death. J. Neurosci. Res. 58: 167–190.
Gross A, McDonnell JM, Korsmeyer SJ. (1999) Blc-2 family members and the mitochondria in apoptosis. Genes and Development 13: 1899–1911.
Oltvai ZN, Milliman CL, Korsmeyer SJ. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog bax, that accelerates programed cell death. Cell 74: 609–619.
Sedlak TW, Oltvai ZN, Yang E, et al. (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA 92: 7834–7838.
Deckwerth TL, Elliott JL, Knudson CM, Johnson EMJ, Snider WD, Korsmeyer SJ. (1996) BAX is required for neuronal death after trophic deprivation and during development. Neuron 17: 1–20.
Miller TM, Moulder KL, Knudson CM, et al. (1997) Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell Biol. 139: 205–217.
White FA, Keller-Peck CR, Knudson CM, Korsmeyer SJ, Snider WD. (1998) Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J. Neurosci. 18: 1428–1439.
Doughty ML, De Jager PL, Korsmeyer SJ, Heintz N. (2000) Neurodegeneration in Lurcher mice occurs via multiple cell death pathways. J. Neurosci. 20: 3687–3694.
Chong MJ, Murray MR, Gosink EC, et al. (2000) Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system. Proc. Natl. Acad. Sci. USA 97: 889–894.
Vanucci RC. (1990) Experimental biology of cerebral hypoxia-ischemia: relation to perinatal brain damage. Pediatr. Res. 27: 317–326.
Volpe JJ (1995) Neurology of the newborn (W. B. Saunders, Philadelphia).
Almli CR, Levy TJ, Han BH, Shah AR, Gidday JM, Holtzman DM. (2000) BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia. Exp. Neurol. 166: 99–114.
Levine S. (1960) Anoxic-ischemic encephalopathy in rats. Am. J. Pathol. 36: 1–17.
Rice JE, Vannucci RC, Brierley JB. (1981) The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9: 131–141.
Ikonomidou C, Mosinger JL, Salles KS, Labruyere J, Olney JW. (1989) Sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J. Neurosci. 9: 2809–2818.
Nakajima W, Ishida A, Lange MS, et al. (2000) Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J Neurosci 20: 7994–8004.
Han BH, DeMattos RB, Dugan LL, et al. (2001) Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat Med 7: 338–343.
Parsadanian AS, Cheng Y, Keller-Peck CR, Holtzman DM, Snider WD. (1998) Bcl-XL is an anti-apoptotic regulator for postnatal CNS neurons. J. Neurosci. 18: 1009–1019.
Lendon CL, Han BH, Salimi K, et al. (2000) No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo. Eur. J. Neurosci. 12: 2235–2242.
Ferriero DM, Holtzman DM, Black SM, Sheldon RA. (1996) Mice without neuronal nitric oxide synthase have less injury after perinatal hypoxia-ischemia. Neurobiol. Dis. 3: 64–71.
Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ, Korsmeyer SJ. (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270: 96–98.
Johnston MV. (1983) Neurotransmitter alterations in a model of perinatal hypoxic-ischemic brain injury. Ann. Neurol. 13: 511–518.
Cheng Y, Gidday JM, Yan Q, Shah AR, Holtzman DM. (1997) Marked age-dependent neuroprotection by BDNF against neonatal hypoxic-ischemic brain injury. Ann. Neurol. 41: 521–529.
Franklin KBJ, Paxinos G (1997) The Mouse Brain in Stereotaxic Coordinates (Academic Press, Inc., San Diego).
Han BH, D’Costa A, Back SA, et al. (2000) BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol. Dis. 7: 38–53.
Han BH, Holtzman DM. (2000) BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J. Neurosci. 20: 5775–5781.
Srinivasan A, Roth KA, Sayers RO, et al. (1998) In Situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death & Diff. 5: 1004–1016.
Velier JJ, Ellison JA, Kikly KK, Spera PA, Barone FC, Feuerstein GZ. (1999) Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat. J. Neurosci. 19: 5932–5941.
Holtzman DM, Bayney RM, Li Y, et al. (1992) Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome. EMBO J. 11: 619–627.
Selznick LA, Holtzman DM, Han BH, et al. (1999) In Situ Immunodetection of neuronal caspase-3 activation in Alzheimer disease. J. Neuropath. Exp. Neurol. 58: 1020–1026.
Northington FJ, Ferriero DM, Graham EM, Traystman RJ, Martin LJ. (2001) Early neurodegeneration after hypoxiaischemia in neonatal rat is necrosis while delayed neuronal death is apoptotis. Neurobiol. Dis. 8: 207–219.
Northington FJ, Ferriero DM, Flock DL, Martin LJ. (2001) Delayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J. Neurosci. 21: 1931–1938.
Han BH, D’Costa A, Back SA, et al. (2000) BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia. Neurobiol. Dis. 7: 38–53.
Deshmukh M, Johnson EM. (1998) Evidence of a novel event during neuronal death—development of competence-to-die in response to cytoplasmic cytochrome C. Neuron 21: 695–705.
Putcha GV, Deshmukh M, Johnson J. E. M. (1999) Bax translocation is a critical event in neuronal apoptosis: regulation by neuroprotectants, bcl-2, and caspases. J. Neurosci. 19: 7476–7485.
Srinivasula SM, Ahmad M, Fernadnes-Alnemri T, Litwack G, Alnemri ES. (1996) Molecular ordering of the Fas-apoptotic pathway: The fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA 93: 14486–14491.
Muzio M, Chinnaiyan AM, Kischkel FC, et al. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas-APO-1) death-inducing signaling complex. Cell 85: 817–827.
Stennicke HR, Jurgensmeier JM, Shin H, et al. (1998) Procaspase-3 is a major physiological target of caspase-8. J. Biol. Chem. 273: 27084–27090.
Felderhoff-Mueser U, Taylor DL, Greenwood K, et al. (2000) Fas/CD95/APO-1 can function as a death receptor for neuronal cells in vitro and in vivo and is upregulated following cerebral hypoxic-ischemic injury to the developing rat brain. Brain Pathol. 10: 17–29.
Martinou J-C, Dubois-Dauphin M, Staple JK, et al. (1994) Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13: 1017–1030.
Chen J, Graham SH, Nakayama M, et al. (1997) Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia. J. Cerebral Blood Flow Metab. 17: 2–10.
Minami M, Jin KL, Li W, Nagayama T, Henshall DC, Simon RP. (2000) Bcl-w expression is increased in brain regions affected by focal cerebral ischemia in the rat. Neurosci. Lett. 279: 193–195.
Yan C, Chen J, Chen D, et al. (2000) Overexpression of the cell death suppressor Bcl-w in ischemic brain: implications for a neuroprotective role via the mitochondrial pathway. J. Cerebral Blood Flow Metab. 20: 620–630.
Krajewski S, Mai JK, Krajewska M, Sikorska M, Mossakowski MJ, Reed JC. (1995) Upregulation of Bax protein levels in neurons following cerebral ischemia. J. Neurosci. 15: 6364–6376.
Hara A, Iwai T, Niwa M, et al. (1996) Immunohistochemical detection of Bax and Bcl-2 proteins in gerbil hippocampus following transient forebrain ischemia. Brain Res. 711: 249–253.
MacGibbon GA, Lawlor PA, Sirimanne ES, et al. (1997) Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer’s disease hippocampus. Brain Res. 750: 223–234.
Cao G, Minami M, Pei W, et al. (2001) Intracellular Bax translocation after transient cerebral ischemia: Implications for a role of the mitochondrial apoptotic signaling pathway in ischemic neuronal death. J. Cereb. Blood Flow & Metab. 21: 321–333.
Kuida K, Zheng TS, Na SQ, et al. (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368–372.
Hakem R, Hakem A, Duncan GS, et al. (1998) Differential requirement fo caspase 9 in apoptotic pathways in vivo. Cell 94: 339–352.
Hara H, Firedlander RM, Gagliardini V, et al. (1997) Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA 94: 2007–2012.
Chen J, Nagayama T, Jin K, et al. (1998) Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 18: 4914–4928.
Rickman DW, Nacke RE, Rickman CB. (1999) Characterization of the cell death promoter, Bad, in the developing rat retina and forebrain. Brain Res. 115: 41–47.
Shimohama S, Fujimoto S, Sumida Y, Tanino H. (1998) Differential Expression of rat brain Bcl-2 family proteins in development and aging. Biochem. Biophys. Res. Comm. 252: 92–96.
Han Z, Bhalla K, Pantazis P, Hendreickson EA, Wyche JH. (1999) Cif (cytochrome c effluxing-inducing factor) activity is regulates by Bcl-2 and caspases and correlates with the activation of Bid. Mol. Cell. Biol. 19: 1381–1389.
Zhai D, Huang X, Han X, Yang F. (2000) Characterization of Bid-induced cytochrome c release from mitochondria and liposomes. FEBS Lett 472: 293–296.
Luo X, Budihardjo I, Zou H, Slaughter C, Wang XD. (1998) BID, a BCL2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481–490.
Li HL, Zhu H, Xu CJ, Yuan JY. (1998) Cleavage of BID by caspase-8 mediates the mitochondrial damage in the FAS pathway of apoptosis. Cell 94: 491–501.
Kuwana T, Smith JJ, Muzio M, Dixit, V., Newmeyer DD, Kornbluth S. (1998) Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J. Biol. Chem. 273: 16589–16594.
Gross A, Yin XM, Wang K, et al. (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-X-L prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274: 1156–1163.
Yin XM, Wang K, Gross A, et al. (1999) Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400: 886–891.
Boldin MP, Goncharov TM, Goltsev YV, Wallach D. (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803–815.
Medema JP, Scaffidi C, Kischkel FC, et al. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16: 2794–2804.
Bertin J, Armstrong RC, Ottilie S, et al. (1997) Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. USA 94: 1172–1176.
Ashkenazi A, Dixit VM. (1998) Death receptors: signaling and modulation. Science 281: 1305–1308.
Budihardjo I, Oliver H, Lutter M, Luo X, Wang XD. (1999) Biochemical pathways of caspase activation during apoptosis. Ann. Rev. Cell Devel. Biol. 15: 269–290.
Ruffolo SC, Breckenridge DG, Nguyen M, et al. (2000) BID-dependent and BID-independent pathways for BAX insertion into mitochondria. Cell Death & Different. 7: 1101–1108.
Wei MC, Zong WX, Cheng EH, et al. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727–730.
Budd SL, Tenneti L, Lishnak T, Lipton SA. (2000) Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc. Natl. Acad. Sci. USA 97: 6161–6166.
Acknowledgments
This work was supported by NIH grant NS35902. The authors thank Eugene Johnson, Mohanish Deshmukh, and Jeff Gidday.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gibson, M.E., Han, B.H., Choi, J. et al. BAX Contributes to Apoptotic-Like Death Following Neonatal Hypoxia-Ischemia: Evidence for Distinct Apoptosis Pathways. Mol Med 7, 644–655 (2001). https://doi.org/10.1007/BF03401871
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03401871